Gyre Therapeutics Inc. (GYRE) — Free Cash Flow Generation Index
Gyre Therapeutics Inc. (GYRE) has a Free Cash Flow Generation Index of 0.94x as of March 2026. Free cash flow of $3.00 Million represents 1% of operating cash flow ($3.18 Million). Explore GYRE capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Gyre Therapeutics Inc. Free Cash Flow Generation Index (2007–2025)
Historical FCF Generation Index trend for Gyre Therapeutics Inc. across 5 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Gyre Therapeutics Inc..
Annual Free Cash Flow Generation for Gyre Therapeutics Inc. (2007–2025)
Year-by-year Free Cash Flow Generation Index for Gyre Therapeutics Inc.. Check GYRE capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.18x | $-180.00K | $1.01 Million | $1.19 Million | ▼ -126.7% |
| 2023 | 0.67x | $17.31 Million | $25.89 Million | $8.59 Million | ▲ +25.7% |
| 2022 | 0.53x | $5.68 Million | $10.68 Million | $5.00 Million | ▼ -45.5% |
| 2010 | 0.98x | $134.99 Million | $138.30 Million | $3.31 Million | ▲ +21.9% |
| 2007 | 0.80x | $19.89 Million | $24.84 Million | $4.94 Million | — |